http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
김맹호,김일현,김광택,김학제 대한흉부심장혈관외과학회 1998 Journal of Chest Surgery (J Chest Surg) Vol.31 No.5
기관무명동맥루는 기관절개술후 드믈게 발생하는 합병증으로 사망률이 높은 질환이며, 치료는 신속한 외과적 처치가 관건이 된다. 환자는 과거력상 30년전에 폐결핵으로 좌측전폐절제술을 시행받았으며 그 동안 경과 양호하였으나 최근 2개월간 급성호흡부전으로 기관절개술을 시행받고 호전되어 11 mm 실리콘 Montgomery T-tube로 교환 후, 3일째 발생한 기관무명동맥루에 의한 절개창주위의 다량의 출혈과 기도폐쇄에 의한 심정지를 일으켰다. 기관무명동맥루에서 Utley maneuver와 무명동맥을 절단봉합하여 지혈에 성공하였고, 이에 지혈방법, 수술수기에 관하여 보고하는 바이다. Tracheoinnominate artery fistula is a rare complication that can happen after tracheostomy, the mortality rate is high and it reqiures urgent surgical management. The patient had received a left pneumonectomy 30 years ago and post-operative course was in uneventful. And tracheostomy was performed for acute respiratory failure due to trachea stenosis for 2 months in recent. She was improved in general condition and changed to a 11 mm silicone Montgomery T-tube. On the 3rd day after the tube changed, she had cardiac arrest due to the excessive hemorrhaging due to tracheoinnominate artery fistula. We report an successusful experience for control of bleeding by an innominate artery fistula division and the Utley maneuver for the tracheoinnominate artery fistula. We report the operation method of bleeding control.
김맹호,김광택,Kim, Maeng-Ho,Kim, Gwang-Taek 대한흉부심장혈관외과학회 1997 Journal of Chest Surgery (J Chest Surg) Vol.30 No.12
활막육종은 원시 간엽세포에서 원발한 악성연조직종양으로 주 호말부위는 슬관절, 족관절에 발생하는 것으로 되어 있으나, 폐에 원발한 활막육종은 거의 보고되지 않았다. 본원은 폐에 원발한 활막육종을 1례 경험하였기에 이에 보고하는 바이다. Synovial sarcoma is a malignant soft tissue tumor originated from primitive mesenchymal cell. It occurs primarily in the paraarticular regions, such as knee joint, ankle joint. We experienced a case of intrapulmonary synovial sarcoma which was originated from the lung.
김맹호 대한흉부심장혈관외과학회 1995 Journal of Chest Surgery (J Chest Surg) Vol.28 No.10
A male 17-year-old boy was tranferred from a private hospital for persistent bilateral pleural effusion.The effusion was confirmed as bilateral chylothorax by chest CT and lymphangiography. Persistent accumulation of the chylothorax was uncontrollable more 1000cc daily ever after pleuroperitoneal shunt operation and thoracoscopic thoracic duct ligation at Rt. side. Chemical pleurodesis with OK 432 into pleural cavity through thoracostomy tube was attempted as 1.5 KE-3 KE diluted in 50ml of normal saline for 3 consecutive days resulted dramatic reduction of the drainage amount. Chemical pleurodesis with OK 432 appeared to be very helpful for management idiopathic bilateral chylothorax.
김맹호,이헌재 대한흉부심장혈관외과학회 1996 Journal of Chest Surgery (J Chest Surg) Vol.29 No.4
본 고려대학교 흉부외과 교실에서는 1990년부터 1994년까지 악성흡수로 진단된 81명을 대상으로 악 성흥수의 임상적 인 증상과 원인을 살펴보고, 이 중 64명을 대상으로 화학적 흥막유착술을 실시하여 그 결과를 관찰하였다. 악성흥수의 가장 많은 원인 질환은 남녀 (27세 ∼82세)모두 폐암으로 50 % 의 빈도를 보였고, 가장 흔 한 증상으로는 호흡기 증상이 였다. 화학적 흥막유착술을 실시한 환자의 평균시술횟수는 4회이 였으며, 1달 이내 흥수가 재발하지 않은 단 기간반웅성공율은 92 % 였고, 1달 이상 흥수의 재발이 없었던 장기간 반응성공율은 94 %로 다른 scler- osant보다 높은 성공률을 볼 수 있었다 또한, 화학적흥막유착술을 실시한 후 발생한 부작용은 주로 발 열과 통증으로 이는 비스테로이드성 소염진통제를 투여하여 조절할 수 있었다 악성흥수의 치료에 OK-4)2로 화학적 흥막유착술을 실시하여 좋은 결과를 얻었기에 이에 보고하는 바이다. To determine the efficacy of OK-432 as pleural sclerosant, we examined the outcomes in 81 patients (age : 27 to 82 years) with malignant pleural effusion and the outcomes in 64 patients ecieving OK-432 3-10KE(1 Klinische Einheit unit) through a chest tube for malignant pleural effusions. Of 81 patients with malignant pleural effusion, 40 patients had lung cancer. Lung cancer is the most frequent cause of malignant pleural effusion in men and women, in which 57 oyo of it was adenocarcinoma. Eighty seven percent of patient had respiratory symptom. Of the 64 patients with intracavitary injection of OK-432 for malignant pleural effusion, 59 patients had a complete short-term response (no fluid reaccumulation during 1 month after intracavitary injection of OK-432). Five patiens of the non-responders had partial control of effusion, with improvement in respiratory symptoms and these patients underwent thoracentesis. Of the 51 patients who survived longer than 1 month, 48 patients did not have re- accumulation of the fluid during follow up. Fever after intracavitary injection of OK-432 was a majors side effect although but that was easily controlled with non-steroidal anti inflammatory drug therapy, Thus the efficacy of intracavitary OK-4)2 injection for malignant pleural effusion was very helpful.